Skip to main content

Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass.

Citation
Alejandro, E. U., et al. “Overexpression Of Kinase-Dead Mtor Impairs Glucose Homeostasis By Regulating Insulin Secretion And Not Β-Cell Mass.”. Diabetes, pp. 2150-2162.
Center University of Michigan
Author Emilyn U Alejandro, Nadejda Bozadjieva, Manuel Blandino-Rosano, Michelle Ann Wasan, Lynda Elghazi, Suryakiran Vadrevu, Leslie Satin, Ernesto Bernal-Mizrachi
Abstract

Regulation of glucose homeostasis by insulin depends on β-cell growth and function. Nutrients and growth factor stimuli converge on the conserved protein kinase mechanistic target of rapamycin (mTOR), existing in two complexes, mTORC1 and mTORC2. To understand the functional relevance of mTOR enzymatic activity in β-cell development and glucose homeostasis, we generated mice overexpressing either one or two copies of a kinase-dead mTOR mutant (KD-mTOR) transgene exclusively in β-cells. We examined glucose homeostasis and β-cell function of these mice fed a control chow or high-fat diet. Mice with two copies of the transgene [RIPCre;KD-mTOR (Homozygous)] develop glucose intolerance due to a defect in β-cell function without alterations in β-cell mass with control chow. Islets from RIPCre;KD-mTOR (Homozygous) mice showed reduced mTORC1 and mTORC2 signaling along with transcripts and protein levels of Pdx-1. Islets with reduced mTORC2 signaling in their β-cells (RIPCre;Rictor) also showed reduced Pdx-1. When challenged with a high-fat diet, mice carrying one copy of KD-mTOR mutant transgene developed glucose intolerance and β-cell insulin secretion defect but showed no changes in β-cell mass. These findings suggest that the mTOR-mediated signaling pathway is not essential to β-cell growth but is involved in regulating β-cell function in normal and diabetogenic conditions.

Year of Publication
2017
Journal
Diabetes
Volume
66
Issue
8
Number of Pages
2150-2162
Date Published
12/2017
ISSN Number
1939-327X
DOI
10.2337/db16-1349
Alternate Journal
Diabetes
PMID
28546423
PMCID
PMC5521866
Download citation